GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (OSTO:PLED BTA) » Definitions » 3-Year Revenue Growth Rate

Egetis Therapeutics AB (OSTO:PLED BTA) 3-Year Revenue Growth Rate : -11.40% (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Egetis Therapeutics AB 3-Year Revenue Growth Rate?

Egetis Therapeutics AB's Revenue per Share for the three months ended in Mar. 2025 was kr0.47.

During the past 12 months, Egetis Therapeutics AB's average Revenue per Share Growth Rate was -36.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -11.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was -34.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Egetis Therapeutics AB was 30.00% per year. The lowest was -57.10% per year. And the median was -25.90% per year.


Competitive Comparison of Egetis Therapeutics AB's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Egetis Therapeutics AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Egetis Therapeutics AB's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Egetis Therapeutics AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Egetis Therapeutics AB's 3-Year Revenue Growth Rate falls into.


;
;

Egetis Therapeutics AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Egetis Therapeutics AB  (OSTO:PLED BTA) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Egetis Therapeutics AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Egetis Therapeutics AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Egetis Therapeutics AB Business Description

Traded in Other Exchanges
Address
Grev Turegatan 11 C, Stockholm, SWE, 114 46
Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.

Egetis Therapeutics AB Headlines

No Headlines